Literature DB >> 23205133

Meta-analysis of the expression of the mitosis-related gene Fam83D.

Lokman Varisli1.   

Abstract

The family with sequence similarity 83, member D (Fam83D) encodes a mitotic spindle-associated protein. Its knockdown results in shorter spindles that fail to organize a correct metaphase plate. In this study, we demonstrated that Fam83D is coexpressed with well-known mitotic genes. Pathway analysis results also showed that cell cycle- and mitosis-related pathways are enriched with Fam83D-coexpressed genes. Furthermore, Fam83D is differentially expressed in various types of cancers. The results presented in this study suggest that Fam83D may be an important molecule for mitotic progression and equal segregation of chromosomes. Since the molecules that are involved in these mechanisms are crucial for mitosis as well as carcinogenesis, Fam83D should be considered as a novel regulator of mitosis and a putative carcinogenesis-related gene.

Entities:  

Year:  2012        PMID: 23205133      PMCID: PMC3506721          DOI: 10.3892/ol.2012.925

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

Review 1.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

2.  The Polo kinase Plk4 functions in centriole duplication.

Authors:  Robert Habedanck; York-Dieter Stierhof; Christopher J Wilkinson; Erich A Nigg
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

Review 3.  Managing the centrosome numbers game: from chaos to stability in cancer cell division.

Authors:  B R Brinkley
Journal:  Trends Cell Biol       Date:  2001-01       Impact factor: 20.808

4.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

Authors:  Torsten Haferlach; Alexander Kohlmann; Lothar Wieczorek; Giuseppe Basso; Geertruy Te Kronnie; Marie-Christine Béné; John De Vos; Jesus M Hernández; Wolf-Karsten Hofmann; Ken I Mills; Amanda Gilkes; Sabina Chiaretti; Sheila A Shurtleff; Thomas J Kipps; Laura Z Rassenti; Allen E Yeoh; Peter R Papenhausen; Wei-Min Liu; P Mickey Williams; Robin Foà
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

5.  Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.

Authors:  Yoshiaki Yamamoto; Hideyasu Matsuyama; Tomoko Furuya; Atsunori Oga; Satoru Yoshihiro; Masaru Okuda; Shigeto Kawauchi; Kohsuke Sasaki; Katsusuke Naito
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

6.  Polo-like kinase 1 is essential for early embryonic development and tumor suppression.

Authors:  Lin-Yu Lu; Jamie L Wood; Katherine Minter-Dykhouse; Lin Ye; Thomas L Saunders; Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2008-09-15       Impact factor: 4.272

7.  Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.

Authors:  Chan Kwon Jung; Ji Han Jung; Kyo Young Lee; Chang Suk Kang; Myungshin Kim; Yoon Ho Ko; Chang Seok Oh
Journal:  Pathol Res Pract       Date:  2007-10-29       Impact factor: 3.250

8.  Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Authors:  Elisa Wurmbach; Ying-bei Chen; Greg Khitrov; Weijia Zhang; Sasan Roayaie; Myron Schwartz; Isabel Fiel; Swan Thung; Vincenzo Mazzaferro; Jordi Bruix; Erwin Bottinger; Scott Friedman; Samuel Waxman; Josep M Llovet
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

9.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

10.  Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway.

Authors:  Brian J Wilson; Vincent Giguère
Journal:  Mol Cancer       Date:  2008-06-04       Impact factor: 27.401

View more
  9 in total

1.  Decreased expression of EFS is correlated with the advanced prostate cancer.

Authors:  Selda Sertkaya; Syed Muhammad Hamid; Nihat Dilsiz; Lokman Varisli
Journal:  Tumour Biol       Date:  2014-10-09

2.  ABCG2 is a potential marker of tumor-initiating cells in breast cancer.

Authors:  Renata Danielle Sicchieri; Willian Abraham da Silveira; Larissa Raquel Mouro Mandarano; Tatiane Mendes Gonçalves de Oliveira; Hélio Humberto Angotti Carrara; Valdair Francisco Muglia; Jurandyr Moreira de Andrade; Daniel Guimarães Tiezzi
Journal:  Tumour Biol       Date:  2015-06-20

3.  Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.

Authors:  Weijia Liao; Weilong Liu; Xing Liu; Qing Yuan; Ying Ou; Yao Qi; Wanqiu Huang; Yun Wang; Jian Huang
Journal:  Oncotarget       Date:  2015-09-15

4.  Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.

Authors:  Antoine M Snijders; Jian-Hua Mao
Journal:  Adv Mod Oncol Res       Date:  2016-07-13

5.  FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer.

Authors:  Minlu Huang; Xinjie Ma; Hongpeng Shi; Lei Hu; Zhiyuan Fan; Li Pang; Fan Zhu; Xiao Yang; Wei Xu; Binya Liu; Zhenggang Zhu; Chen Li
Journal:  Oncotarget       Date:  2017-08-10

6.  FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.

Authors:  Xuling Liu; Hong Gao; Jie Zhang; Dongying Xue
Journal:  Biosci Rep       Date:  2019-05-07       Impact factor: 3.840

7.  Prognostic significance of FAM83D gene expression across human cancer types.

Authors:  Peter J Walian; Bo Hang; Jian-Hua Mao
Journal:  Oncotarget       Date:  2016-01-19

Review 8.  FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.

Authors:  Courtney A Bartel; Neetha Parameswaran; Rocky Cipriano; Mark W Jackson
Journal:  Oncotarget       Date:  2016-08-09

9.  G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.

Authors:  Junjie Zhao; Xuhong Fu; Hao Chen; Lingqiang Min; Jie Sun; Jingyi Yin; Jianping Guo; Haojie Li; Zhaoqing Tang; Yuanyuan Ruan; Xuefei Wang; Yihong Sun; Liyu Huang
Journal:  Br J Cancer       Date:  2020-09-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.